APTV vs NVR

The deterministic health scores present a mixed picture: the Piotroski F-Score of 4/9 indicates stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a high current P/E of 58.82, the forward P/E of 9.01 suggests strong earnings growth expectations. The company beats earnings estimates consistently, with a 3/4 beat rate over the last four quarters and an average surprise of 14.89%, yet insider selling and weak long-term price performance raise caution. While analysts are bullish with a $101.81 target price and a 'buy' recommendation, the stock trades at a significant premium to the Graham Number of $35.41, implying high valuation risk.

NVR exhibits significant fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a severe disconnect between its current price ($6315.87) and its Graham Number ($3565.6). While the balance sheet remains liquid with a low Debt/Equity ratio of 0.30, the company is facing a sharp contraction in both revenue (-21.40% YoY) and earnings (-28.50% YoY). The valuation is unsustainable given a PEG ratio of 4.97 and a price nearly double its growth-based intrinsic value. Combined with bearish insider selling and a negative technical trend, the outlook is poor at current valuation levels.